Structures by: Thanikasalam K.
Total: 15
2-Amino-4-methoxy-6-methylpyrimidinium hydrogen phthalate
C6H10N3O,C8H5O4
IUCrData (2016) 1, 5 x160794
a=7.3951(4)Å b=9.0021(4)Å c=10.5163(4)Å
α=97.298(3)° β=92.096(3)° γ=90.4322(18)°
2-Amino-4-methoxy-6-methylpyrimidin-1-ium trifluoroacetate
C6H10N3O,C2F3O2
IUCrData (2016) 1, 6 x161010
a=4.8087(2)Å b=11.0283(5)Å c=11.1135(5)Å
α=108.704(3)° β=96.174(3)° γ=100.533(3)°
Ethyl (<i>E</i>)-4-[(4-Hydroxy-3-methoxy-5-nitrobenzylidene)amino]benzoate
C17H16N2O6
Acta Crystallographica Section E (2018) 74, 8 1079-1082
a=4.7565(3)Å b=11.3377(9)Å c=15.7590(13)Å
α=70.415(4)° β=87.230(4)° γ=85.238(4)°
R-2,c-6-Di(p-tolyl)-t-3,t-5-dimethyltetrahydropyran-4-one
C21H24O2
Acta Crystallographica Section E (2003) 59, 4 o461-o462
a=9.0894(18)Å b=25.813(3)Å c=15.1605(10)Å
α=90.00° β=90.00° γ=90.00°
R-2,c-6-di(4-chlorophenyl)-t-3,t-5-dimethyltetrahydropyran-4-one
C19H18Cl2O2
Acta Crystallographica Section E (2003) 59, 4 o463-o465
a=15.0130(10)Å b=9.1230(16)Å c=25.462(4)Å
α=90.00° β=90.00° γ=90.00°
4-Furoyl-2,3,4,5,6,7-hexahydro-r-2,c-7-diphenyl-1H-1,4-diazepin-5-one
C22H20N2O3
Acta Crystallographica Section E (2003) 59, 8 o1117-o1119
a=8.9941(2)Å b=19.8913(4)Å c=10.3244(2)Å
α=90.00° β=90.00° γ=90.00°
1-Benzyl-2-[(2RS,3SR,6SR)-3-methyl-4-oxo-2,6-diphenylpiperidin-1-ylcarbonyl]- 2-phenylethenyl phenylacetate
C42H37NO4
Acta Crystallographica Section E (2006) 62, 4 o1443-o1445
a=9.3027(3)Å b=12.1333(5)Å c=14.5927(6)Å
α=88.7510(17)° β=78.574(3)° γ=85.653(2)°
(2RS,3SR,6SR)-3-ethyl-2,6-diphenyl-1-phenylacetyl-4-piperidone
C27H27NO2
Acta Crystallographica Section E (2006) 62, 4 o1452-o1454
a=19.355(6)Å b=22.944(8)Å c=9.959(3)Å
α=90.00° β=97.905(6)° γ=90.00°
(2RS,4RS)-N-Acetyl-2,3,4,5-tetrahydro-2,4-diphenyl-1,5-benzothiazepine
C23H21NOS
Acta Crystallographica Section C (2004) 60, 6 o421-o426
a=20.3579(4)Å b=8.30140(10)Å c=22.2513(4)Å
α=90.00° β=93.8650(10)° γ=90.00°
(2RS,4RS)-N-Chloroacetyl-2,3,4,5-tetrahydro-2,4-diphenyl-1,5-benzothiazepine
C23H20ClNOS
Acta Crystallographica Section C (2004) 60, 6 o421-o426
a=12.6348(4)Å b=11.9337(5)Å c=12.7904(5)Å
α=90.00° β=92.549(2)° γ=90.00°
(2RS,4RS)-N-Benzoyl-2,3,4,5-tetrahydro-2,4-diphenyl-1,5-benzothiazepine
C28H23NOS
Acta Crystallographica Section C (2004) 60, 6 o421-o426
a=30.1891(8)Å b=14.8005(3)Å c=9.7965(3)Å
α=90.00° β=102.2570(16)° γ=90.00°
(R)-2,3,4,5-Tetrahydro-2,2,4-trimethyl-1,5-benzothiazepine
C12H17NS
Acta Crystallographica Section C (2004) 60, 5 o346-o349
a=7.2644(4)Å b=7.8657(3)Å c=10.1522(5)Å
α=90.00° β=103.190(2)° γ=90.00°
Rac-5-benzoyl-2,3,4,5-tetrahydro-2,2,4-trimethyl-1,5-benzothiazepine
C19H21NOS
Acta Crystallographica Section C (2004) 60, 5 o346-o349
a=16.1757(2)Å b=12.5444(3)Å c=8.2147(2)Å
α=90.00° β=90.00° γ=90.00°
(2RS,6SR)-N-diphenylacetyl-2,6-diphenyl-4-piperidone
C31H27NO2
Acta Crystallographica Section C (2006) 62, 6 o324-o327
a=11.2499(2)Å b=11.8622(3)Å c=18.2320(5)Å
α=90.00° β=107.8750(15)° γ=90.00°
(2RS,3SR,5RS,6SR)-3,5-dimethyl-N-phenylacetyl-2,6-diphenyl-4-piperidinone
C27H27NO2
Acta Crystallographica Section C (2006) 62, 6 o324-o327
a=9.9503(4)Å b=11.8623(6)Å c=18.5654(8)Å
α=77.920(2)° β=84.699(3)° γ=85.731(2)°